Neuroblastoma in the first year of life. The Italian contribution to a study of the Internation Society of Paediatric Oncology Europe Neuroblastoma Group
Andrea Di Cataldo(University of Catania), Bruno De Bernardi(Istituto Giannina Gaslini), Maurizio Bianchi, Francesco De Leonardis(University of Bari Aldo Moro), Richard A. Balter, Carlo Cosmi(University of Sassari), Roberto Luksch(Fondazione IRCCS Istituto Nazionale dei Tumori), S Bagnulo, Başak Aru(Yeditepe University), Claudio Granata(Istituto Giannina Gaslini), K. Tettoni(Brescia University), I Mazzarino(University of Perugia), Paolo Pierani(Ospedali Riuniti di Ancona), R. Serino, Giulio Andrea Zanazzo(IRCCS Materno Infantile Burlo Garofolo), Marco Nardi(University of Pisa), A. Tamburini, Massimo Provenzi(University of Bergamo), Luca Tonegatti(Brescia University), Mario Giuliano(Regione Campania), Gian Battista Parigi(Policlinico San Matteo Fondazione), M. S. Scotta(University of St.Gallen), Massimo Conte(Istituto Giannina Gaslini), Roberta Pericoli(Ospedale Infermi di Rimini), V. Bombace(University of Catania), Stefano Mastrangelo, L Miglionico(Nuovo Ospedale San Giovanni di Dio), Paolo D’Angelo(TXT e-solutions (Italy)), Elisabetta Viscardi(Azienda Ospedale - Università Padova), Gregoria Bertuna(University of Catania), Giuseppina Paone(University of Bologna), F Bonetti(Policlinico San Matteo Fondazione), Anna Maria Fagnani(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giampaolo Arcamone(University of Bari Aldo Moro), Aurora Castellano, Monica Cellini(University of Modena and Reggio Emilia), Roberta Migliorati(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli)
Unknown
August 1, 2006
Cited by 1
Related Papers
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268